Barclays’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Hold
1
﹤0.01% 4545
2025
Q1
$0 Sell
1
-63,247
-100% ﹤0.01% 4537
2024
Q4
$65K Buy
63,248
+63,247
+6,324,700% +$65K ﹤0.01% 3897
2024
Q3
$0 Sell
1
-54,511
-100% ﹤0.01% 4423
2024
Q2
$19K Sell
54,512
-167,543
-75% -$58.4K ﹤0.01% 3907
2024
Q1
$149K Sell
222,055
-102,332
-32% -$68.7K ﹤0.01% 3479
2023
Q4
$176K Buy
324,387
+179,036
+123% +$97.1K ﹤0.01% 3556
2023
Q3
$87K Sell
145,351
-19,668
-12% -$11.8K ﹤0.01% 3375
2023
Q2
$214K Sell
165,019
-213,997
-56% -$278K ﹤0.01% 3049
2023
Q1
$666K Sell
379,016
-119,448
-24% -$210K ﹤0.01% 2436
2022
Q4
$1.57M Buy
498,464
+132,924
+36% +$418K ﹤0.01% 1789
2022
Q3
$1.79M Buy
365,540
+262,234
+254% +$1.28M ﹤0.01% 1738
2022
Q2
$428K Buy
103,306
+38,773
+60% +$161K ﹤0.01% 2690
2022
Q1
$374K Sell
64,533
-120,293
-65% -$697K ﹤0.01% 2974
2021
Q4
$1.39M Buy
184,826
+71,799
+64% +$538K ﹤0.01% 2008
2021
Q3
$1.02M Sell
113,027
-5,717
-5% -$51.5K ﹤0.01% 2245
2021
Q2
$1.42M Sell
118,744
-132,243
-53% -$1.58M ﹤0.01% 1922
2021
Q1
$3.15M Sell
250,987
-87,171
-26% -$1.09M ﹤0.01% 1537
2020
Q4
$5.28M Sell
338,158
-12,269
-4% -$191K ﹤0.01% 1003
2020
Q3
$3.31M Buy
350,427
+13,533
+4% +$128K ﹤0.01% 1190
2020
Q2
$3.02M Buy
336,894
+71,481
+27% +$640K ﹤0.01% 1213
2020
Q1
$1.69M Buy
265,413
+30,941
+13% +$197K ﹤0.01% 1419
2019
Q4
$1.96M Buy
234,472
+19,540
+9% +$164K ﹤0.01% 1895
2019
Q3
$1.94M Sell
214,932
-99,659
-32% -$901K ﹤0.01% 1783
2019
Q2
$3.39M Buy
314,591
+154,909
+97% +$1.67M ﹤0.01% 1374
2019
Q1
$1.52M Buy
159,682
+98,044
+159% +$935K ﹤0.01% 1792
2018
Q4
$708K Sell
61,638
-16,336
-21% -$188K ﹤0.01% 2043
2018
Q3
$1.32M Sell
77,974
-41,765
-35% -$708K ﹤0.01% 2086
2018
Q2
$1.7M Buy
119,739
+27,079
+29% +$384K ﹤0.01% 1521
2018
Q1
$1.76M Buy
92,660
+11,775
+15% +$224K ﹤0.01% 1439
2017
Q4
$1.33M Buy
80,885
+46,230
+133% +$758K ﹤0.01% 1480
2017
Q3
$520K Buy
34,655
+647
+2% +$9.71K ﹤0.01% 1896
2017
Q2
$299K Sell
34,008
-9,275
-21% -$81.5K ﹤0.01% 2208
2017
Q1
$226K Sell
43,283
-2,540
-6% -$13.3K ﹤0.01% 2422
2016
Q4
$140K Buy
45,823
+6,680
+17% +$20.4K ﹤0.01% 2475
2016
Q3
$181K Buy
39,143
+22,844
+140% +$106K ﹤0.01% 2173
2016
Q2
$94K Sell
16,299
-1,864
-10% -$10.8K ﹤0.01% 2365
2016
Q1
$109K Buy
18,163
+4,063
+29% +$24.4K ﹤0.01% 2290
2015
Q4
$126K Sell
14,100
-8,070
-36% -$72.1K ﹤0.01% 2221
2015
Q3
$111K Sell
22,170
-6,105
-22% -$30.6K ﹤0.01% 2337
2015
Q2
$311K Sell
28,275
-30,262
-52% -$333K ﹤0.01% 1931
2015
Q1
$879K Sell
58,537
-46,406
-44% -$697K ﹤0.01% 1665
2014
Q4
$1.58M Buy
104,943
+21,077
+25% +$316K ﹤0.01% 1413
2014
Q3
$838K Buy
83,866
+35,018
+72% +$350K ﹤0.01% 1764
2014
Q2
$733K Sell
48,848
-12,983
-21% -$195K ﹤0.01% 1839
2014
Q1
$1.11M Sell
61,831
-38,944
-39% -$701K ﹤0.01% 1611
2013
Q4
$1.31M Buy
100,775
+88,552
+724% +$1.15M ﹤0.01% 1609
2013
Q3
$122K Sell
12,223
-12,518
-51% -$125K ﹤0.01% 2858
2013
Q2
$193K Buy
+24,741
New +$193K ﹤0.01% 2709